Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study
European Journal of Nutrition · 2026-06 · 65 (4)
DOI: 10.1007/s00394-026-03971-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Nutrition, online erschienen am 11.06.2026. Verfasst von Arig Elbira und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Nutrition, Faculty of Environment, University of Leeds, Leeds, LS2 9JT, UK. Hauptthemen laut MEDLINE: Postprandial Period, Blood Glucose, Pea Proteins. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Libyan government, BBSRC/IUK.
Abstract (Originalsprache)
Purpose
Protein intake has shown benefits to mitigate postprandial hyperglycaemic excursions. In particular, whey protein has demonstrated strong potential for postprandial glucose management, and more recent findings highlighted evidence for increased efficacy of whey protein when consumed before, rather than with a carbohydrate-rich meal. Given the strong interest yet limited evidence on plant-based protein, the present study compared the potential of pea protein consumed prior to carbohydrates, on postprandial glucose as well as satiety and blood pressure (BP).
Methods
In an acute randomized cross-over trial, ten healthy adults consumed a pea protein drink either before (PrePP) or with (PP) a standard carbohydrate-rich meal, compared with a control meal (CHO). Continuous glucose monitoring, satiety levels and BP were recorded over 180 min post-meal consumption.
Results
Both PP and PrePP significantly reduced postprandial glucose excursion (0.46 vs. 1.125 mmol/L), compared to CHO (1.89 mmol/L). The effect was more pronounced with PrePP, exhibiting a delayed glucose response and a blunted peak beyond 60 min. Systolic BP remained unchanged, whereas both PP and PrePP significantly reduced diastolic BP compared to CHO (− 4.2 mmHg at 150 min, p < 0.05; −9.2 mmHg at 180 min, p < 0.01, respectively). PP significantly increased fullness and reduced hunger after 60 and 180 min, respectively, whereas PrePP significantly decreased hunger after 60 min of carbohydrate consumption.
Conclusion
Given the enhanced efficacy in lowering postprandial glucose when consumed before carbohydrates, pea protein pre-meal consumption could be considered as part of a dietary strategy to manage postprandial glycaemia well comparable to whey protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Science and Nutrition, Faculty of Environment, University of Leeds, Leeds, LS2 9JT, UK.
- National Alternative Protein Innovation Centre (NAPIC), Leeds, UK.
- School of Food Science and Nutrition, Faculty of Environment, University of Leeds, Leeds, LS2 9JT, UK. c.bosch@leeds.ac.uk.
- National Alternative Protein Innovation Centre (NAPIC), Leeds, UK. c.bosch@leeds.ac.uk.
ORCID-Profile: Alan Javier Hernández-Álvarez
Förderung
- Libyan government
- BBSRC/IUK
Zitieren
APA
Elbira, A., Punithalayal, P. G. G., Hernández-Álvarez, A. J., & Boesch, C. (2026). Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. European Journal of Nutrition, 65(4). https://doi.org/10.1007/s00394-026-03971-3
Vancouver
Elbira A, Punithalayal PGG, Hernández-Álvarez AJ, Boesch C. Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study. European Journal of Nutrition. 2026;65(4). doi:10.1007/s00394-026-03971-3
BibTeX
@article{Elbira2026,
author = {Elbira, Arig and Punithalayal, Priscilla Grace Gnanasekaran and Hernández-Álvarez, Alan Javier and Boesch, Christine},
title = {Pea protein preload improves postprandial glucose response in healthy adults: a randomized, double-blind, controlled pilot study},
journal = {European Journal of Nutrition},
year = {2026},
volume = {65},
number = {4},
doi = {10.1007/s00394-026-03971-3}
}
EUVIMED